September 23, 2013
The 11,900-square-meter compression molding plant manufactures components used for packaging injectable drugs, supplying customers primarily in China and the Asia-Pacific region. Construction began in June 2011.
“West is experiencing an exciting period of growth in the Asia-Pacific region and we are proud to complete our second manufacturing facility in China,” said Donald E. Morel, Jr., West’s Chairman and Chief Executive Officer. “This facility will provide better service to our customers, offering shorter lead times for delivery of our world-class pharmaceutical packaging products and creating new, flexible capacity to meet the growing demands for our products in China and throughout the Asia-Pacific region. Our investment in this new facility demonstrates our commitment to and confidence in the China market.
“On behalf of West’s Board of Directors and our employees worldwide, I would like to thank representatives of the Chinese government and the Shanghai Zhangjiang High-Tech Industrial Development Zone Qingpu Park, in particular, for their continued support throughout the construction of the new facility.”
“The Project Team for this facility includes representatives from our global team in China, Germany and Singapore, reflecting the strength and reach of our business,” said Warwick Bedwell, President, Asia-Pacific Region. “This plant continues our global expansion plans and is a perfect complement to the injection molding plant already established in Qingpu. Our talented management team in China has worked hard to fulfill this important business objective that will further fuel our business growth. I thank the commitment and teamwork displayed by all our West colleagues who worked on this project. It was truly an exceptional global effort.”